• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶型和组织型纤溶酶原激活剂作为人成纤维细胞的生长因子。

Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.

作者信息

De Petro G, Copeta A, Barlati S

机构信息

Department of Biomedical Sciences and Biotechnologies, University of Brescia, Italy.

出版信息

Exp Cell Res. 1994 Jul;213(1):286-94. doi: 10.1006/excr.1994.1200.

DOI:10.1006/excr.1994.1200
PMID:8020601
Abstract

In this study we have verified the mitogenic effect of urokinase-type (u-PA) and tissue-type plasminogen activators (t-PA) on human normal fibroblasts. We report that both PAs can induce DNA replication and cell division in serum-deprived cultured human skin fibroblasts. The activity of u-PA and t-PA is, respectively, three- and twofold more potent than that exerted by epidermal growth factor (EGF) with an activity slightly lower (50-60%) than that induced by basic fibroblast growth factor (bFGF). The u-PA and t-PA, but not plasmin, induced DNA synthesis, which could be neutralized by anti-u-PA and anti-t-PA antibodies, respectively, but was insensitive to aprotinin treatment. The addition of anti-u-PA-receptor (u-PAR) monoclonal antibodies to the assays selectively suppressed the mitogenic effect exerted by u-PA, but not that of t-PA, and the amino-terminal fragment of u-PA, containing the EGF-like domain and the kringle module, did not elicit any mitogenic activity. Anti-bFGF antibodies completely suppressed the mitogenic activity of bFGF, but did not have any effect on that of u-PA and t-PA; the activity of both PAs was inhibited by anti-fibronectin IgG concentrations ineffective on bFGF. These results indicate that PAs may be considered growth factors of human fibroblasts.

摘要

在本研究中,我们验证了尿激酶型纤溶酶原激活剂(u-PA)和组织型纤溶酶原激活剂(t-PA)对人正常成纤维细胞的促有丝分裂作用。我们报告称,两种纤溶酶原激活剂均可在血清饥饿培养的人皮肤成纤维细胞中诱导DNA复制和细胞分裂。u-PA和t-PA的活性分别比表皮生长因子(EGF)高两倍和一倍,其活性略低于碱性成纤维细胞生长因子(bFGF)诱导的活性(50-60%)。u-PA和t-PA可诱导DNA合成,但纤溶酶不能,u-PA和t-PA诱导的DNA合成可分别被抗u-PA和抗t-PA抗体中和,但对抑肽酶处理不敏感。在实验中加入抗u-PA受体(u-PAR)单克隆抗体可选择性抑制u-PA的促有丝分裂作用,但不影响t-PA的促有丝分裂作用,且含有EGF样结构域和kringle模块的u-PA氨基末端片段不具有任何促有丝分裂活性。抗bFGF抗体可完全抑制bFGF的促有丝分裂活性,但对u-PA和t-PA的促有丝分裂活性没有任何影响;两种纤溶酶原激活剂的活性均被对bFGF无效的抗纤连蛋白IgG浓度所抑制。这些结果表明,纤溶酶原激活剂可被视为人类成纤维细胞的生长因子。

相似文献

1
Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts.尿激酶型和组织型纤溶酶原激活剂作为人成纤维细胞的生长因子。
Exp Cell Res. 1994 Jul;213(1):286-94. doi: 10.1006/excr.1994.1200.
2
Induction of fibronectin mRNA by urokinase- and tissue-type plasminogen activator in human skin fibroblasts: differential role of u-PA and t-PA at the fibronectin protein level.
Biol Chem. 2002 Jan;383(1):177-87. doi: 10.1515/BC.2002.018.
3
Synergistic induction of t-PA by vascular endothelial growth factor and basic fibroblast growth factor and localization of t-PA to Weibel-Palade bodies in bovine microvascular endothelial cells.血管内皮生长因子和碱性成纤维细胞生长因子对牛微血管内皮细胞中组织型纤溶酶原激活物的协同诱导作用及其在魏贝尔-帕拉德小体中的定位
Thromb Haemost. 2001 Aug;86(2):702-9.
4
Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.人肝星状细胞中纤维蛋白溶解系统的功能及其受碱性成纤维细胞生长因子和血小板衍生生长因子的调控
Hepatology. 1999 Mar;29(3):868-78. doi: 10.1002/hep.510290343.
5
Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.无血清原代大鼠肝细胞培养物中尿激酶的存在及其在激活肝细胞生长因子中的作用。
Cancer Res. 1996 Jun 15;56(12):2837-43.
6
Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.尿激酶(u-PA)由集合管主细胞产生,并在转录后受到SV40大T抗原、精氨酸加压素和表皮生长因子的调控。
J Cell Physiol. 2006 Feb;206(2):394-401. doi: 10.1002/jcp.20485.
7
Mitogenic action of tumor necrosis factor in human fibroblasts: interaction with epidermal growth factor and platelet-derived growth factor.肿瘤坏死因子在人成纤维细胞中的促有丝分裂作用:与表皮生长因子和血小板衍生生长因子的相互作用。
J Cell Physiol. 1988 Apr;135(1):23-31. doi: 10.1002/jcp.1041350104.
8
Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.人成纤维细胞和转染人尿激酶受体的小鼠成纤维细胞中,趋化性和促有丝分裂性尿激酶受体相互作用后第二信使的产生。
Exp Cell Res. 1994 Aug;213(2):438-48. doi: 10.1006/excr.1994.1221.
9
Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.人类成纤维细胞的恶性转化与受体结合型纤溶酶原激活物活性增加相关。
Cancer Res. 1991 Feb 15;51(4):1221-6.
10
Transcriptional regulation of tissue- and urokinase-type plasminogen activator genes by thrombin in human fetal lung fibroblasts.凝血酶对人胎儿肺成纤维细胞中组织型和尿激酶型纤溶酶原激活剂基因的转录调控
Thromb Haemost. 1995 Aug;74(2):704-10.

引用本文的文献

1
Methylthioadenosine (MTA) boosts cell-specific productivities of Chinese hamster ovary cultures: dosage effects on proliferation, cell cycle and gene expression.甲硫基腺苷(MTA)提高中国仓鼠卵巢细胞培养物的细胞特异性生产力:对增殖、细胞周期和基因表达的剂量效应
FEBS Open Bio. 2020 Dec;10(12):2791-2804. doi: 10.1002/2211-5463.13019. Epub 2020 Nov 11.
2
Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.尿激酶型纤溶酶原激活物增加了骨骼肌再生所需的肝细胞生长因子的活性。
Blood. 2009 Dec 3;114(24):5052-61. doi: 10.1182/blood-2008-12-196212. Epub 2009 Oct 7.
3
Proteomic identification of LASP-1 down-regulation after RNAi urokinase silencing in human hepatocellular carcinoma cells.
RNA干扰沉默人肝癌细胞中尿激酶后LASP-1下调的蛋白质组学鉴定
Neoplasia. 2009 Feb;11(2):207-19. doi: 10.1593/neo.81076.
4
Tissue plasminogen activator induces pancreatic cancer cell proliferation by a non-catalytic mechanism that requires extracellular signal-regulated kinase 1/2 activation through epidermal growth factor receptor and annexin A2.组织型纤溶酶原激活剂通过一种非催化机制诱导胰腺癌细胞增殖,该机制需要通过表皮生长因子受体和膜联蛋白A2激活细胞外信号调节激酶1/2。
Am J Pathol. 2007 May;170(5):1573-84. doi: 10.2353/ajpath.2007.060850.
5
Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence.纤溶酶原激活物抑制剂-1是p53在诱导复制性衰老过程中的关键下游靶点。
Nat Cell Biol. 2006 Aug;8(8):877-84. doi: 10.1038/ncb1448. Epub 2006 Jul 23.
6
Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.尿激酶型纤溶酶原激活剂在人胃癌细胞系(AGS)中的过表达可诱导严重联合免疫缺陷小鼠产生致瘤性。
Jpn J Cancer Res. 2002 Feb;93(2):151-6. doi: 10.1111/j.1349-7006.2002.tb01253.x.
7
Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.丝氨酸蛋白酶催化释放尿激酶型纤溶酶原激活剂N端片段对人上皮性卵巢癌生长刺激的自分泌调节
Biochem J. 1999 Aug 1;341 ( Pt 3)(Pt 3):765-9.
8
Urokinase plasminogen activator induces human smooth muscle cell migration and proliferation via distinct receptor-dependent and proteolysis-dependent mechanisms.尿激酶型纤溶酶原激活剂通过不同的受体依赖性和蛋白水解依赖性机制诱导人平滑肌细胞迁移和增殖。
Mol Cell Biochem. 1999 May;195(1-2):199-206. doi: 10.1023/a:1006936623106.
9
Oestradiol regulation of the components of the plasminogen-plasmin system in MDA-MB-231 human breast cancer cells stably expressing the oestrogen receptor.雌激素对稳定表达雌激素受体的MDA-MB-231人乳腺癌细胞中纤溶酶原-纤溶酶系统各成分的调节作用
Br J Cancer. 1998 Jul;78(1):88-95. doi: 10.1038/bjc.1998.447.
10
Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.组织型纤溶酶原激活剂是肿瘤抑制基因maspin的一个靶点。
Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):499-504. doi: 10.1073/pnas.95.2.499.